CT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Approvals
Operations
Outsourced Services
Supply Chain
Data Management
Medical Devices
Themes
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Product & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Reports
Premium Insights
Excellence Awards
Innovation Rankings
Magazine
Newsletters
GlobalData
About Us
Advertise With Us
Contact Us
Our Marketing Solution
GlobalData Reports
Visit GlobalData
From Our Partners
Optimizing Cell & Gene Therapy Processes
Accelerating Clinical Trials
Advancing research with digital-first clinical trials
Improving decentralised trials with mobile research nursing
The new era of global patient recruitment
The next chapter of clinical trial services
Trusted clinical trial packaging services
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
Pipeline moves: Approval prospects for SBS candidate rise after Phase III trial meets endpoints
Tackling the unmet therapeutic needs in stimulant use disorder
Pipeline moves: Prospects drop after investigator-led trial of Roche’s Tecentriq terminated
Sectors
Sections
Clinical Trials
Approvals
Operations
Outsourced Services
Supply Chain
Data Management
Medical Devices
Latest
Phesgo for the Treatment of HER2-Positive Breast Cancer, US
Lundbeck initiates Lu AG09222 migraine prevention trial
Lantern Pharma begins subject dosing in non-Hodgkin’s lymphoma trial
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
BeiGene spin-out Pi Health raises $30m to uptick cancer trial enrolment
Sativex (Nabiximols) for the Treatment of Multiple Sclerosis, Europe
Kiromic activates new clinical site for Phase I NSCLC treatment trial
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Q4 2023 update: M&A activity in pharmaceutical in the US
Q4 2023 update: M&A activity in pharmaceutical in Middle East and Africa
Q4 2023 update: M&A activity in pharmaceutical in Italy
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
Empowering clinical trials: The technological revolution in patient retention
PRPs: What is a Patient Recruitment Platform (and why do you need one)?
Quality versus quantity in T-cell production: Why it doesn’t have to be a trade-off
Events
Reports
Premium Insights
Newsletters
CT
About Global Defence Technology Magazine